Editorial
A forgotten dimension of big data in drug repositioning
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.113277 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Elie Rassy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France; CESP, INSERM U1018, Université Paris-Saclay, Villejuif, F…. Hauptthemen laut MEDLINE: Big Data, Drug Repositioning. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Big DataDrug RepositioningHumans
Autor:innen und Institutionen
- Department of Medical Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France; CESP, INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: elie.el-rassy@gustaveroussy.fr.
- Department of Medical Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Gustave Roussy, INSERM U981, Université Paris-Saclay, Villejuif, France.
Zitieren
APA
Rassy, E., & Andre, F. (2023). A forgotten dimension of big data in drug repositioning. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113277
Vancouver
Rassy E, Andre F. A forgotten dimension of big data in drug repositioning. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113277
BibTeX
@article{Rassy2023,
author = {Rassy, Elie and Andre, Fabrice},
title = {A forgotten dimension of big data in drug repositioning},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.113277}
}
EUVIMED